Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
A Phase 2 study designed to evaluate the efficacy and safety of CM512 in adult patients with moderate-to-severe Atopic Dermatitis (AD).
Epistemonikos ID: c688ba022200d4f9e1c9d3972f55a6c2a07bb3e7
First added on: Apr 29, 2025